Navigation Links
Octapharma Group and Fresenius Kabi Enter Into an Exclusive License, Development and Supply Agreement for a HESylated Recombinant Protein
Date:10/28/2009

BAD HOMBURG, Germany and LACHEN, Switzerland, Oct. 28 /PRNewswire/ -- Octapharma Group and Fresenius Kabi have signed a License, Development and Supply Agreement regarding the use of Fresenius Kabi's HESylation® Technology to develop a HESylated recombinant protein.

Under the agreement, Fresenius Kabi will license its proprietary HESylation® Technology to Octapharma. This technology platform is based on hydroxyethyl starch ("HES") which will be combined with a recombinant protein from Octapharma's human cell-line platform -- this combination is intended to generate a therapeutic protein with a superior product profile.

Fresenius Kabi will seek to adapt and optimize the protein modification by its HESylation® Technology and will afterwards be responsible for providing the appropriate HES derivative to Octapharma. Under the agreement, Octapharma will oversee the further development and commercialization. Fresenius Kabi will receive up-front and milestone payments, research funding and royalties on sales for licensing of the HESylation® Technology.

Octapharma's human cell-line platform

Octapharma's core business is the development, production and sale of high quality human protein therapies from both human plasma and human cell lines. Over the last twelve years, Octapharma has successfully established the human HEK293F cell-line platform for the expression of a variety of recombinant therapeutic proteins on a commercial scale.

An investigational new drug application for Octapharma's human cell-line derived recombinant FVIII was filed in the U.S. in May 2008. Using a human cell-line expression system instead of e.g. hamster cell-lines is expected to result in possible advantages like improved protein functions, increased tolerability and the opportunity for reduced immunogenicity.

HESylation® Technology

HESylation® Technology is based on th
'/>"/>

SOURCE Octapharma
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Plasma Products Safe Despite Swine Influenza Outbreak, Assures International Biopharmaceutical Company Octapharma
2. Octapharma Accepting Applications for Research Grants on Immunotherapy, Coagulation Disorders and Critical Care
3. Octapharma Targeting the Major Risk of Hemophilia Treatment - FVIII Antibodies
4. Baxter and The Alzheimers Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimers Disease
5. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
6. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
7. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
8. Ethics Group Asks USAID Inspector General to Investigate Legality of Grants to Soros Groups
9. Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline
10. Coley Pharmaceutical Group Diversifies Pipeline with First-in-Class TLR Antagonist for the Treatment of Systemic Lupus Erythematosus
11. Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... -- This industry report package offers the most up-to-date market data on the ... world and in the top 10 global countries. Along with a global ... countries: Australia , China ... Italy , Japan , Russia ... , United States The reports include ...
(Date:3/3/2015)... , March 3, 2015 /CNW/ - The ... seized a health product being injected at Art Nails Ltd., located ... appeared to be unauthorized as it contained no labelling. All products ... authorized by Health Canada and must have approved labelling. ... had been administered to consumers. Potential risks associated with injecting an ...
(Date:3/3/2015)... , March 3, 2015 ... 356 and 240 patients respectively Publications in ... Journal of Clinical Gastroenterology highlight diagnostic value of ... China and across ... Kea Technologies (Euronext: MKEA, FR0010609263), inventor of Cellvizio®, the ...
Breaking Medicine Technology:Global Safety Glass Market to 2019 - Market Size, Top 10 Countries, Trends, and Forecasts 2Advisory - Health product seized from Art Nails in Vancouver 2Two New Publications From Leading Team in China Present Data From Large Clinical Trials Highlighting Advantages of Cellvizio in Diagnosis of Gastric and Esophageal Cancers 2Two New Publications From Leading Team in China Present Data From Large Clinical Trials Highlighting Advantages of Cellvizio in Diagnosis of Gastric and Esophageal Cancers 3Two New Publications From Leading Team in China Present Data From Large Clinical Trials Highlighting Advantages of Cellvizio in Diagnosis of Gastric and Esophageal Cancers 4
(Date:3/3/2015)... DePuy Pinnacle hip lawsuits (( ... the artificial hip system caused recipients to suffer ... in the federal multidistrict litigation underway in U.S. ... the most recent Master Case List issued by ... hip replacement lawsuits are now pending in the ...
(Date:3/3/2015)... With a grant of more than $4.5 ... has been named a national coordinating center by the ... for Health: Improving Community Health Through Innovations in Financing ... health and reduce disparities through innovations in collaboration and ... of the center and up to 10 communities over ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 Dallas ... as chairman of the upcoming Dallas Rhinoplasty Symposium, to ... three day symposium, which is attended by plastic surgeons ... provide surgeons with detailed information on current topics, emerging ... revision rhinoplasty surgery . , The symposium will ...
(Date:3/3/2015)... March 03, 2015 Retrofit , ... at America’s leading corporations, today announces the appointment of ... executive positions. CEO Mary Pigatti has recruited ... and employee engagement for the fast-growing company, which was ... watch for 2015. , “Retrofit is thrilled to ...
(Date:3/3/2015)... Celestix Networks, the leading provider ... the global availability of Celestix Cloud Edge Security ... most deployed platform for DirectAccess and remote access ... new release enables organizations to manage the Windows® ... single HTML 5 web interface called Comet 2.0. ...
Breaking Medicine News(10 mins):Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 2Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 3Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 4Health News:Robert Wood Johnson Foundation Names Georgia Health Policy Center National Center for Bridging for Health Initiative 2Health News:Dr. Rod Rohrich to Chair 32nd Annual Dallas Rhinoplasty Symposium 2Health News:Dr. Rod Rohrich to Chair 32nd Annual Dallas Rhinoplasty Symposium 3Health News:Retrofit Signals Growth: Corporate Weight Management Company Announces Talent Acquisitions 2Health News:Retrofit Signals Growth: Corporate Weight Management Company Announces Talent Acquisitions 3Health News:Retrofit Signals Growth: Corporate Weight Management Company Announces Talent Acquisitions 4Health News:Introducing Celestix Cloud Edge Security 2.0 for Increased Security in DirectAccess Client Management 2Health News:Introducing Celestix Cloud Edge Security 2.0 for Increased Security in DirectAccess Client Management 3
... medicine is world renowned. It has supernatural effects on ... such article was recently reported in the November 7 ... the great significance of a Chinese medicinal compound, delisheng, ... method. The research team was led by Dr. Ke-Jun ...
... ID at-risk patients years before clinical diagnosis, scientists say ... An international team of scientists has developed a blood ... impairment will go on to develop Alzheimer,s disease. , ... of effective treatments against Alzheimer,s in the future -- ...
... October 15, 2007 New research presented at ... College of Gastroenterology emphasizes the importance of colorectal ... who have a higher incidence of colorectal cancer ... African-Americans had advanced polyps on the right side ...
... 2007 Post-hoc and other analyses of secondary endpoints ... plc,s (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) ulcerative colitis ... in patients with mild to moderate ulcerative colitis. These ... open-label 12-14 month extension study, are being presented this ...
... Level I and II,Trauma Center accreditation status has been ... 2007 through,September 30, 2008: Regional Resource Trauma Center (Level ... Johnstown -- Conemaugh Memorial Medical Center ... Philadelphia -- Hahnemann University Hospital ...
... TORONTO, Oct. 15 /PRNewswire-FirstCall/ - Bradmer Pharmaceuticals ... of cancer therapies, today announced that it held ... Drug Administration (FDA) at,which the FDA concurred with ... its lead drug, Neuradiab, a treatment for newly ...
Cached Medicine News:Health News:A Chinese medicine compound has satisfactory anti-cancer effects on hepatocellular carcinoma 2Health News:Blood Test Might Spot Alzheimer's Early 2Health News:Blood Test Might Spot Alzheimer's Early 3Health News:Racial and ethnic differences in colorectal cancer emphasize importance of screening 2Health News:New Analyses of long-term LIALDA (mesalamine) data presented at ACG 2Health News:New Analyses of long-term LIALDA (mesalamine) data presented at ACG 3Health News:New Analyses of long-term LIALDA (mesalamine) data presented at ACG 4Health News:Pennsylvania Trauma Center Accreditation Status 2Health News:Bradmer provides Phase III Neuradiab trial update and guidance 2Health News:Bradmer provides Phase III Neuradiab trial update and guidance 3
... The e.cam single-detector system offers ... unrestricted access for gurneys and ... a clinically versatile open gantry, ... body contouring for SPECT and ...
In Stainless steel. Available in 1.5, 2.0,3.0 & 3.5 MM...
Spring Type with lock. Titanium....
The REVEALRT and REVEALXVI PET/CT scanners combine our fastest PET scanner, the REVEALXL, with multi-slice spiral CT scanners from Siemens Medical Systems....
Medicine Products: